Home Cart 0 Sign in  
X

[ CAS No. 1074-86-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1074-86-8
Chemical Structure| 1074-86-8
Chemical Structure| 1074-86-8
Structure of 1074-86-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1074-86-8 ]

Related Doc. of [ 1074-86-8 ]

Alternatived Products of [ 1074-86-8 ]

Product Details of [ 1074-86-8 ]

CAS No. :1074-86-8 MDL No. :MFCD01632221
Formula : C9H7NO Boiling Point : -
Linear Structure Formula :- InChI Key :JFDDFGLNZWNJTK-UHFFFAOYSA-N
M.W : 145.16 Pubchem ID :333703
Synonyms :
4-formyl Indole;NSC 337264
Chemical Name :1H-Indole-4-carbaldehyde

Calculated chemistry of [ 1074-86-8 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 43.69
TPSA : 32.86 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.11 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.24
Log Po/w (XLOGP3) : 1.51
Log Po/w (WLOGP) : 1.98
Log Po/w (MLOGP) : 0.88
Log Po/w (SILICOS-IT) : 2.69
Consensus Log Po/w : 1.66

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.23
Solubility : 0.853 mg/ml ; 0.00588 mol/l
Class : Soluble
Log S (Ali) : -1.81
Solubility : 2.26 mg/ml ; 0.0156 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.21
Solubility : 0.0897 mg/ml ; 0.000618 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.05

Safety of [ 1074-86-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H317-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1074-86-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1074-86-8 ]
  • Downstream synthetic route of [ 1074-86-8 ]

[ 1074-86-8 ] Synthesis Path-Upstream   1~40

  • 1
  • [ 1074-85-7 ]
  • [ 1074-86-8 ]
YieldReaction ConditionsOperation in experiment
80% With 4-methylmorpholine N-oxide In dichloromethane at 20℃; for 1 h; Molecular sieve Tetrapropylammonium perruthenate (0.3 g, 0.85 mmol) was added in portions to a mixture of alcohol product from Step A (2.5 g, 17 mmol), N-methylmorpholine N-oxide (3.0 g, 25 mmol) and 4 A molecular sieves (3.0 g) in anhydrous methylene chloride (30 mL) at room temperature.
The mixture was stirred at room temperature under nitrogen for 1 h and then filtered.
The filtrate was concentrated in vacuo, and the residue was purified by chromatography (SiO2, CH2Cl2) to provide indole-4-aldehyde as a white powder (2.0 g, 80percent): 1H NMR (300 MHz, CDCl3) δ10.2 (s, 1H), 8.52 (br s, 1H), 7.64-7.69 (m, 2H), 7.31-7.44 (m, 3H), CI MS m/z=146 [C9H7NO+H]+.
53%
Stage #1: With Dess-Martin periodane In dichloromethane for 1 h;
Stage #2: With water In diethyl ether; dichloromethane; water
b) lH-Indole-4-carbaldehyde; Dess-Martin periodane (1.04 g, 2.46 mmol) was dissolved into anhydrous CH2Cl2 (10 ml). (lH-Indol-4-yi)-methanol (449 mg, 3.07 mmol) in anhydrous CH2Cl2 (10 ml) was added and the mixture was stirred for 1 h. Sodium hydroxide (50ml of IN solution) and ether (50 ml) were added and the reaction was stirred for 30 min. The organic layer was separated and washed with water (10 ml), brine (10 ml), dried over MgSO4, filtered and concentrated to a thick brown oil. Purification by column chromatography (silica gel, gradient elution of 2percent MeOH/CH2Cl2 to 5percent MeOH/CH2Cl2) gave lH-indole-4- <n="163"/>carbaldehyde (235 mg, 53percent) as a yellow solid: 1HNMR (300 MHz, DMSOd6) 5 11.59 (bs, IH), 10.18 (s, IH), 7.78-7.75 (m, IH), 7.66-7.60 (m, 2H), 7.33-7.28 (m, IH), 7.08 (d, J = 3.0 Hz, IH).
Reference: [1] Journal of Organic Chemistry, 1980, vol. 45, # 16, p. 3350 - 3352
[2] Journal of Medicinal Chemistry, 2002, vol. 45, # 26, p. 5755 - 5775
[3] Bioorganic and Medicinal Chemistry Letters, 1998, vol. 8, # 8, p. 983 - 988
[4] Patent: US2006/111385, 2006, A1, . Location in patent: Page/Page column 20
[5] Chemistry Letters, 1980, p. 813 - 816
[6] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1992, # 23, p. 3211 - 3218
[7] Patent: WO2007/53131, 2007, A2, . Location in patent: Page/Page column 161-162
[8] Helvetica Chimica Acta, 1954, vol. 37, p. 1826
  • 2
  • [ 1074-85-7 ]
  • [ 114615-82-6 ]
  • [ 1074-86-8 ]
YieldReaction ConditionsOperation in experiment
80% With 4-methylmorpholine N-oxide In dichloromethane Step B:
Tetrapropylammonium perruthenate (0.3 g, 0.85 mmol) was added in portions to a mixture of alcohol product from Step A (2.5 g, 17 mmol), N-methylmorpholine N-oxide (3.0 g, 25 mmol) and 4 A molecular sieves (3.0 g) in anhydrous methylene chloride (30 mL) at room temperature.
The mixture was stirred at room temperature under nitrogen for 1 h and then filtered.
The filtrate was concentrated in vacuo, and the residue was purified by chromatography (SiO2, CH2Cl2) to provide indole-4-aldehyde as a white powder (2.0 g, 80percent): 1H NMR (300 MHz, CDCl3) δ 10.2 (s, 1H), 8.52 (br s, 1H), 7.64-7.69 (m, 2H), 7.31-7.44 (m, 3H); CI MS m/z=146 [C9H7NO+H]+.
Reference: [1] Patent: US2002/91134, 2002, A1,
  • 3
  • [ 16136-52-0 ]
  • [ 1074-86-8 ]
Reference: [1] Tetrahedron, 1983, vol. 39, # 22, p. 3695 - 3706
[2] Heterocycles, 1987, vol. 26, # 5, p. 1173 - 1176
[3] Journal of Medicinal Chemistry, 2010, vol. 53, # 6, p. 2646 - 2650
  • 4
  • [ 112447-73-1 ]
  • [ 1074-86-8 ]
Reference: [1] Tetrahedron Letters, 1987, vol. 28, # 30, p. 3453 - 3456
  • 5
  • [ 76499-46-2 ]
  • [ 1074-86-8 ]
Reference: [1] Journal of Organic Chemistry, 1981, vol. 46, # 8, p. 1752 - 1755
  • 6
  • [ 39830-66-5 ]
  • [ 1074-86-8 ]
Reference: [1] Journal of Medicinal Chemistry, 2002, vol. 45, # 26, p. 5755 - 5775
[2] Bioorganic and Medicinal Chemistry Letters, 1998, vol. 8, # 8, p. 983 - 988
[3] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1992, # 23, p. 3211 - 3218
[4] Journal of Organic Chemistry, 1980, vol. 45, # 16, p. 3350 - 3352
[5] Helvetica Chimica Acta, 1954, vol. 37, p. 1826
  • 7
  • [ 3468-22-2 ]
  • [ 1074-86-8 ]
Reference: [1] Chemistry Letters, 1980, p. 813 - 816
[2] Chemistry Letters, 1980, p. 813 - 816
  • 8
  • [ 59382-59-1 ]
  • [ 1074-86-8 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1992, # 23, p. 3211 - 3218
[2] Journal of Organic Chemistry, 1980, vol. 45, # 16, p. 3350 - 3352
  • 9
  • [ 73816-11-2 ]
  • [ 1074-86-8 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1992, # 23, p. 3211 - 3218
[2] Journal of Organic Chemistry, 1980, vol. 45, # 16, p. 3350 - 3352
  • 10
  • [ 83-41-0 ]
  • [ 1074-86-8 ]
Reference: [1] Journal of Organic Chemistry, 1981, vol. 46, # 8, p. 1752 - 1755
[2] Archiv der Pharmazie, 1990, vol. 323, # 3, p. 145 - 155
  • 11
  • [ 23876-11-1 ]
  • [ 1074-86-8 ]
Reference: [1] Journal of Organic Chemistry, 1981, vol. 46, # 8, p. 1752 - 1755
[2] Archiv der Pharmazie, 1990, vol. 323, # 3, p. 145 - 155
  • 12
  • [ 76499-33-7 ]
  • [ 1074-86-8 ]
Reference: [1] Journal of Organic Chemistry, 1981, vol. 46, # 8, p. 1752 - 1755
[2] Archiv der Pharmazie, 1990, vol. 323, # 3, p. 145 - 155
  • 13
  • [ 79681-04-2 ]
  • [ 1074-86-8 ]
Reference: [1] Heterocycles, 1986, vol. 24, # 7, p. 1987 - 1996
  • 14
  • [ 1975-50-4 ]
  • [ 1074-86-8 ]
Reference: [1] Journal of Organic Chemistry, 1980, vol. 45, # 16, p. 3350 - 3352
  • 15
  • [ 23876-12-2 ]
  • [ 1074-86-8 ]
Reference: [1] Archiv der Pharmazie, 1990, vol. 323, # 3, p. 145 - 155
  • 16
  • [ 19384-71-5 ]
  • [ 1074-86-8 ]
Reference: [1] Journal of Heterocyclic Chemistry, 2000, vol. 37, # 5, p. 1293 - 1297
  • 17
  • [ 55289-35-5 ]
  • [ 1074-86-8 ]
Reference: [1] Journal of Organic Chemistry, 1986, vol. 51, # 26, p. 5106 - 5110
  • 18
  • [ 105205-47-8 ]
  • [ 1074-86-8 ]
Reference: [1] Journal of Organic Chemistry, 1986, vol. 51, # 26, p. 5106 - 5110
  • 19
  • [ 42792-95-0 ]
  • [ 1074-86-8 ]
Reference: [1] Chemistry Letters, 1980, p. 813 - 816
[2] Chemistry Letters, 1980, p. 813 - 816
[3] Chemistry Letters, 1980, p. 813 - 816
  • 20
  • [ 75446-71-8 ]
  • [ 1074-86-8 ]
Reference: [1] Chemistry Letters, 1980, p. 813 - 816
[2] Chemistry Letters, 1980, p. 813 - 816
[3] Chemistry Letters, 1980, p. 813 - 816
  • 21
  • [ 88059-19-2 ]
  • [ 1074-86-8 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1985, vol. 22, p. 121 - 125
  • 22
  • [ 35577-89-0 ]
  • [ 1074-86-8 ]
Reference: [1] Heterocycles, 1986, vol. 24, # 7, p. 1987 - 1996
  • 23
  • [ 95969-07-6 ]
  • [ 1074-86-8 ]
Reference: [1] Heterocycles, 1986, vol. 24, # 7, p. 1987 - 1996
  • 24
  • [ 76989-06-5 ]
  • [ 1074-86-8 ]
Reference: [1] Heterocycles, 1986, vol. 24, # 7, p. 1987 - 1996
  • 25
  • [ 106486-88-8 ]
  • [ 1074-86-8 ]
Reference: [1] Heterocycles, 1986, vol. 24, # 7, p. 1987 - 1996
  • 26
  • [ 106486-87-7 ]
  • [ 1074-86-8 ]
Reference: [1] Heterocycles, 1986, vol. 24, # 7, p. 1987 - 1996
  • 27
  • [ 106486-86-6 ]
  • [ 1074-86-8 ]
Reference: [1] Heterocycles, 1986, vol. 24, # 7, p. 1987 - 1996
  • 28
  • [ 74068-99-8 ]
  • [ 1074-86-8 ]
Reference: [1] Chemistry Letters, 1980, p. 813 - 816
  • 29
  • [ 75446-77-4 ]
  • [ 1074-86-8 ]
Reference: [1] Chemistry Letters, 1980, p. 813 - 816
  • 30
  • [ 127693-25-8 ]
  • [ 4637-24-5 ]
  • [ 1074-86-8 ]
  • [ 127693-05-4 ]
Reference: [1] Archiv der Pharmazie, 1990, vol. 323, # 3, p. 145 - 155
  • 31
  • [ 2124-55-2 ]
  • [ 1074-86-8 ]
Reference: [1] Helvetica Chimica Acta, 1954, vol. 37, p. 1826
[2] Helvetica Chimica Acta, 1954, vol. 37, p. 1826
  • 32
  • [ 53269-35-5 ]
  • [ 1074-86-8 ]
Reference: [1] Heterocycles, 1987, vol. 26, # 5, p. 1173 - 1176
  • 33
  • [ 110811-33-1 ]
  • [ 1074-86-8 ]
Reference: [1] Heterocycles, 1987, vol. 26, # 5, p. 1173 - 1176
  • 34
  • [ 50614-84-1 ]
  • [ 1074-86-8 ]
Reference: [1] Helvetica Chimica Acta, 1954, vol. 37, p. 1826
  • 35
  • [ 52488-36-5 ]
  • [ 68-12-2 ]
  • [ 1074-86-8 ]
Reference: [1] Journal of Organic Chemistry, 1986, vol. 51, # 26, p. 5106 - 5110
  • 36
  • [ 1074-86-8 ]
  • [ 3468-18-6 ]
YieldReaction ConditionsOperation in experiment
88% With sodium borohydrid; methylamine In methanol; water Step C:
To a solution of aldehyde product from Step B (2.0 g, 14 mmol) in methanol (100 mL), 40percent methylamine in water (2.27 mL, 27.6 mmol) was added at room temperature over a period of 10 min.
The mixture was stirred at room temperature under nitrogen overnight and then was cooled down to 0° C. Sodium borohydride (1.05 g, 27.6 mmol) was added.
The reaction mixture was slowly warmed to room temperature for 2 h.
Most of methanol was removed in vacuo, and the residue was diluted with water and extracted (3*) with ether.
The combined organic layers were extracted with 2 N HCl (100 mL).
The HCl layer was made basic (pH~11) with 2 N NaOH and extracted (3*) with methylene chloride.
The combined organic layers were washed with brine, dried over Na2SO4, and concentrated in vacuo to give crude 4-(aminomethyl)-indole as a white powder (1.95 g, 88percent): 1H NMR (300 MHz, CDCl3) δ 8.29 (s, br, 1H), 7.31 (d, J=8.0 Hz, 1H), 7.22 (t, J=2.7 Hz, 1H), 7.16 (t, J=8.0, 7.3 Hz, 1H), 7.08 (d, J=7.3 Hz, 1H), 6.64 (t, J=2.0 Hz, 1H), 4.06 (s, 2H), 2.51 (s, 3H); CI MS m/z=160 [C10H12N2+H]+.
Reference: [1] Patent: US2002/91134, 2002, A1,
  • 37
  • [ 1074-86-8 ]
  • [ 74-88-4 ]
  • [ 133994-99-7 ]
YieldReaction ConditionsOperation in experiment
99%
Stage #1: With sodium hydride In N,N-dimethyl-formamide at 20℃; for 0.666667 h;
Stage #2: at 20℃; for 12 h;
a) 1 -Methyl-lH-indole-4-carbaldehyde; To a solution of lH-indole-4-carbaldehyde (413 mg, 2.85 mmol) in anhydrous DMF (6.5 niL) was added sodium hydride (171 mg of 60percent dispersion in oil, 4.27 mmol). The mixture was stirred for 40 min at room temperature. Methyl iodide (0.36 mL, 5.78 mmol) was then added and the reaction mixture was stirred for 12 h at room temperature. Water was added (25 mL) and the mixture was extracted with ethyl acetate (3x 25 mL). Combined organic layers were washed with water (20 mL) and brine (20 mL), dried over Na2SO4, filtered and concentrated to a yellow oil. Purification by column chromatography (silica gel, CH2Cl2) gave l-methyl-lH-indole-4-carbaldehyde (452 mg g, 99percent) as a yellow oil: 1H NMR (400 MHz, DMSO-^) δ 10.20 (s, IH), 7.84 (d, J= 8.0 Hz, IH), 7.68 (d, J= 7.2 Hz, IH), 7.58 (d, J= 2.8 Hz, IH), 7.38-7.34 (m, IH), 7.08 (d, J= 3.2 Hz, IH), 3.87 (s, 3H).
89%
Stage #1: With sodium hydride In N,N-dimethyl-formamide at 0℃; for 0.0833333 h; Inert atmosphere
Stage #2: for 0.5 h; Inert atmosphere
To the solution of 28 in dimethylformamide (DMF) maintained at 0 °C was added sodium hydride (NaH, 0.36 g, 10.32 mmol) and was stirred for 5 min before adding methylidodide (MeI, 0.44 mL, 8.25 mmol) and the reaction was stirred for 30 min. Reaction was quenched by slow addition of water at 0 °C and extracted using EtOAc (25 mL 3). The combined organic layer was collected, dried over anhydrous MgSO4 andconcentrated under reduced pressure to give a pale yellow residue,which was purified by silica gel chromatography (EtOAc: Hexane,4:1) to give 31 as off white residue in 89percent yield; 1H NMR (300 MHz,CDCl3): δ 3.89 (s, 3H), 7.26-7.28 (m, 2H), 7.38 (t, J=8.1 Hz, 1H), 7.46(t, J=8.1 Hz, 2H), 10.27 (s, 1H).
70%
Stage #1: With caesium carbonate In acetonitrile at 60℃; for 2 h;
Stage #2: at 60℃; for 1 h;
General procedure: To a solution of indole-aldehyde (435mg 3mmol) in CH3CN (30mL) was added Cs2CO3 (829mg, 6mmol), and the mixture was refluxed for 2h. To this solution, alkyl halide (3.3mmol) was added, and the mixture was heated under reflux for 1h. After the completion of the reaction, the solvent was evaporated under reduced pressure and water was added to the reaction mixture and extracted 3 times for ethyl acetate. The combined organic layers were dried over Na2SO4 and concentrated under vacuum. The residue was purified by flash chromatography.
Reference: [1] Patent: WO2007/53131, 2007, A2, . Location in patent: Page/Page column 178
[2] European Journal of Medicinal Chemistry, 2017, vol. 134, p. 13 - 23
[3] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 7, p. 2060 - 2079
[4] Journal of Organometallic Chemistry, 2011, vol. 696, # 5, p. 1072 - 1083
[5] Patent: WO2012/47702, 2012, A1, . Location in patent: Page/Page column 32
[6] Organic and Biomolecular Chemistry, 2017, vol. 15, # 35, p. 7404 - 7410
  • 38
  • [ 1074-86-8 ]
  • [ 2472-88-0 ]
  • [ 74-88-4 ]
  • [ 133994-99-7 ]
Reference: [1] Patent: US5086070, 1992, A,
  • 39
  • [ 1074-86-8 ]
  • [ 75-03-6 ]
  • [ 894852-86-9 ]
YieldReaction ConditionsOperation in experiment
99%
Stage #1: With sodium hydride In N,N-dimethyl-formamide at 20℃; for 0.5 h;
Stage #2: at 20℃; for 12 h;
a) l-ethyl-lH-indole-4-carbaldehvde; <n="181"/>To a solution of lH-indole-4-carbaldehyde (2.00 g, 13.8 mmol) in anhydrous DMF (6.5 niL) was added sodium hydride (827 mg of 60percent dispersion in oil, 20.7 mmol). The mixture was stirred for 30 min at room temperature. Ethyl iodide (2.22 mL, 27.5 mmol) was then added and the reaction mixture was stirred for 12 h at room temperature. Water was added (100 mL) and the mixture was extracted with ethyl acetate (3x 100 mL). Combined organic layers were washed with brine (100 mL), dried over Na2SO4, filtered and concentrated to an orange oil. Purification by column chromatography (silica gel, gradient elution Of CH2Cl2 to 5percent MeOH/CH2Cl2) gave the title compound (1-ethyl-lH- indole-4-carbaldehyde) (2.43 g, 99percent) as a yellow oil: 1H NMR (300 MHz, OMSOd6) δ 10.19 (s, IH), 7.88 (d, J= 8.1 Hz, IH), 7.68-7.64 (m, 2H), 7.37-7.32 (m, IH), 7.08 (d, J= 3.0, IH), 4.28 (q, J= 7.2 Hz, 2H), 1.36 (t, J= 7.2 Hz, 3H).
78%
Stage #1: With caesium carbonate In acetonitrile at 60℃; for 2 h;
Stage #2: at 60℃; for 1 h;
General procedure: To a solution of indole-aldehyde (435mg 3mmol) in CH3CN (30mL) was added Cs2CO3 (829mg, 6mmol), and the mixture was refluxed for 2h. To this solution, alkyl halide (3.3mmol) was added, and the mixture was heated under reflux for 1h. After the completion of the reaction, the solvent was evaporated under reduced pressure and water was added to the reaction mixture and extracted 3 times for ethyl acetate. The combined organic layers were dried over Na2SO4 and concentrated under vacuum. The residue was purified by flash chromatography.
Reference: [1] Patent: WO2007/53131, 2007, A2, . Location in patent: Page/Page column 179-180
[2] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 7, p. 2060 - 2079
  • 40
  • [ 1074-86-8 ]
  • [ 1145678-74-5 ]
Reference: [1] Patent: WO2013/26914, 2013, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1074-86-8 ]

Aldehydes

Chemical Structure| 5416-80-8

[ 5416-80-8 ]

2-Methyl-1H-indole-3-carbaldehyde

Similarity: 0.96

Chemical Structure| 4771-49-7

[ 4771-49-7 ]

6-Methyl-1H-indole-3-carbaldehyde

Similarity: 0.96

Chemical Structure| 52562-50-2

[ 52562-50-2 ]

5-Methyl-1H-indole-3-carbaldehyde

Similarity: 0.96

Chemical Structure| 487-89-8

[ 487-89-8 ]

Indole-3-carboxaldehyde

Similarity: 0.96

Chemical Structure| 141835-34-9

[ 141835-34-9 ]

5-Phenyl-1H-indole-3-carbaldehyde

Similarity: 0.96

Related Parent Nucleus of
[ 1074-86-8 ]

Indoles

Chemical Structure| 5416-80-8

[ 5416-80-8 ]

2-Methyl-1H-indole-3-carbaldehyde

Similarity: 0.96

Chemical Structure| 4771-49-7

[ 4771-49-7 ]

6-Methyl-1H-indole-3-carbaldehyde

Similarity: 0.96

Chemical Structure| 52562-50-2

[ 52562-50-2 ]

5-Methyl-1H-indole-3-carbaldehyde

Similarity: 0.96

Chemical Structure| 487-89-8

[ 487-89-8 ]

Indole-3-carboxaldehyde

Similarity: 0.96

Chemical Structure| 141835-34-9

[ 141835-34-9 ]

5-Phenyl-1H-indole-3-carbaldehyde

Similarity: 0.96